Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Impact Of Covid-19 On Genetic Testing Market
3.2. Key Market Trends
3.3. Porter’S Five Forces Analysis
3.3.1. Buyers Power
3.3.2. Suppliers Power
3.3.3. Substitution
3.3.4. New Entrants
3.3.5. Industry Rivalry
3.4. Opportunity Matrix
3.5. Vendor Landscape
3.6. Value Chain Analysis
3.7. Key Buying Criteria
3.8. Regulatory Framework

4. Market By Type
4.1. Prenatal And Newborn Testing
4.2. Diagnostic Testing
4.3. Predictive & Presymptomatic Testing
4.4. Carrier Testing
4.5. Pharmacogenomic Testing
4.6. Other Types

5. Market By Technology
5.1. Molecular Testing
5.2. Cytogenetic Testing
5.3. Biochemical Testing

6. Market By Application
6.1. Genetic Disease Diagnosis
6.2. Cancer Diagnosis
6.3. Cardiovascular Disease Diagnosis
6.4. Other Applications

7. Market By Disease
7.1. Cancer
7.2. Cystic Fibrosis
7.3. Huntington’S Disease
7.4. Sickle Cell Anaemia
7.5. Duchenne Muscular Dystrophy
7.6. Alzheimer’S Disease
7.7. Rare Disease
7.8. Thalassemia
7.9. Other Diseases

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions & Divestitures
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. Biorad Laboratories
8.2.3. Illumina Inc
8.2.4. Myriad Genetics Inc
8.2.5. Perkinelmer Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Value Chain Analysis
Figure 6: United States Genetic Testing Market, Growth Potential, By Type, In 2021
Figure 7: United States Genetic Testing Market, By Prenatal And Newborn Testing Genetic Testing, 2022-2028 (In $ Million)
Figure 8: United States Genetic Testing Market, By Diagnostic Testing, 2022-2028 (In $ Million)
Figure 9: United States Genetic Testing Market, By Carrier Testing, 2022-2028 (In $ Million)
Figure 10: United States Genetic Testing Market, By Pharmacogenomic Testing, 2022-2028 (In $ Million)
Figure 11: United States Genetic Testing Market, Growth Potential, By Technology, In 2021
Figure 12: United States Genetic Testing Market, By Molecular Testing, 2022-2028 (In $ Million)
Figure 13: United States Genetic Testing Market, By Cytogenetic Testing, 2022-2028 (In $ Million)
Figure 14: United States Genetic Testing Market, By Biochemical Testing, 2022-2028 (In $ Million)
Figure 15: United States Genetic Testing Market, Growth Potential, By Application, In 2021
Figure 16: United States Genetic Testing Market, By Genetic Disease Diagnosis, 2022-2028 (In $ Million)
Figure 17: United States Genetic Testing Market, By Cancer Diagnosis, 2022-2028 (In $ Million)
Figure 18: United States Genetic Testing Market, By Cardiovascular Diseases Diagnosis, 2022-2028 (In $ Million)
Figure 19: United States Genetic Testing Market, By Other Applications, 2022-2028 (In $ Million)
Figure 20: United States Genetic Testing Market, Growth Potential, By Disease, In 2021
Figure 21: United States Genetic Testing Market, By Cancer, 2022-2028 (In $ Million)
Figure 22: United States Genetic Testing Market, By Cystic Fibrosis, 2022-2028 (In $ Million)
Figure 23: United States Genetic Testing Market, By Huntington’S Disease, 2022-2028 (In $ Million)
Figure 24: United States Genetic Testing Market, Sickle Cell Anemia, 2022-2028 (In $ Million)
Figure 25: United States Genetic Testing Market, By Duchenne Muscular Dystrophy, 2022-2028 (In $ Million)
Figure 26: United States Genetic Testing Market, By Alzheimer’S Disease, 2022-2028 (In $ Million)
Figure 27: United States Genetic Testing Market, By Rare Diseases, 2022-2028 (In $ Million)
Figure 28: United States Genetic Testing Market, By Thalassemia, 2022-2028 (In $ Million)
Figure 29: United States Genetic Testing Market, By Other Diseases, 2022-2028 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: COUNTRY SNAPSHOT - GENETIC TESTING
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: UNITED STATES GENETIC TESTING MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: UNITED STATES GENETIC TESTING MARKET, BY TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 5: UNITED STATES GENETIC TESTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: UNITED STATES GENETIC TESTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 7: UNITED STATES GENETIC TESTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: UNITED STATES GENETIC TESTING MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 9: UNITED STATES GENETIC TESTING MARKET, BY DISEASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: UNITED STATES GENETIC TESTING MARKET, BY DISEASE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 11: LEADING PLAYERS OPERATING IN UNITED STATES GENETIC TESTING MARKET
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES